Low tumour interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study. Authors´reply

Bibliographic Details
Published in:	Pulmonology
Main Authors:	Seyer Safi, Axel Benner, Philipp Beckhove, Thomas Muley
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Lung neoplasms Biomarker Cytokines Tumor mikroenvironment IL-1β
Online Access:	https://www.tandfonline.com/doi/10.1080/25310429.2024.2447637

Similar Items

Interleukin‐11 promotes lung adenocarcinoma tumourigenesis and immune evasion
by: Cristina Cirauqui, et al.
Published: (2025-07-01)

Diagnostic Accuracy of Interleukin-6, Interleukin-8, and Interleukin-10 for Predicting Bacteremia in Children with Febrile Neutropenia
by: Zümrüt Şahbudak Bal, et al.
Published: (2017-08-01)

Interleukin 18 expression in the primary breast cancer tumour tissue
by: Nahida Srabović, et al.
Published: (2011-02-01)

Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy
by: Seiichiro Kusuhara, et al.
Published: (2021-05-01)

Diagnostic value of cerebrospinal fluid levels of D-lactate, tumour necrosis factor-alpha and interleukin-6, -8, and -17 in suspected nosocomial meningitis
by: Sibel Yorulmaz Goktas, et al.
Published: (2024-08-01)

Correspondence: Predicting treatment response to adjuvant platinum-based chemotherapy and prognosis following pulmonary adenocarcinoma surgery
by: Xiping Shen, et al.
Published: (2025-12-01)

Cytokine dynamics in vitiligo: the roles of interleukin-10 and interleukin-17
by: Hanan Mohammed Saied
Published: (2025-08-01)

Interleukin-31: A Pro-inflammatory Oriented Cytokine
by: Giuseppe Murdaca, et al.
Published: (2025-06-01)

Interleukin 18 and interleukin 22 as important immune markers in patients with tuberculosis
by: Kamoona Firas Mohammad Hussein, et al.
Published: (2023-01-01)

Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
by: Kazuhisa Furue, et al.
Published: (2017-10-01)

Features of interleukin-17 and interleukin-23 expression in patients with inflammatory bowel diseases
by: Yu.M. Stepanov, et al.
Published: (2025-03-01)

Interleukin-10 inhibits interleukin-1β production and inflammasome activation of microglia in epileptic seizures
by: Yi Sun, et al.
Published: (2019-03-01)

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
by: Gabeen AA, et al.
Published: (2014-06-01)

The association of 25(OH)D, interleukin-4, interleukin-5, and interleukin-13 levels with the burden of soil-transmitted helminth infection in stunted children aged 24–59 months
by: Riyadi Adrizain, et al.
Published: (2024-12-01)

FEATURES OF INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION AND RECEPTION IN AUTOIMMUNE THYROID DISORDERS
by: T. V. Saprina
Published: (2014-07-01)

Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict the Severity in Patients With COVID-19
by: Kuan Luo, et al.
Published: (2021-12-01)

Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
by: Riley D. Metcalfe, et al.
Published: (2020-07-01)

Rhodomyrtus tomentosa (Aiton) Hassk. (haramonting) protects against allethrin-exposed pulmo damage in rats: mechanistic interleukins
by: Putri Cahaya Situmorang, et al.
Published: (2024-02-01)

Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy
by: Anissa A. Widjaja, et al.
Published: (2020-10-01)

Elevated interleukin-10, -22, -24, and -26 in serum samples of children with infectious mononucleosis
by: Li Dalei, et al.
Published: (2025-01-01)

Adjuvant chemotherapy can benefit the survival of stage I lung adenocarcinoma patients with tumour spread through air spaces after resection: Propensity-score matched analysis
by: Shaonan Xie, et al.
Published: (2022-08-01)

Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib
by: Zhang SS, et al.
Published: (2022-04-01)

IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells
by: Franziska Christine Sanna, et al.
Published: (2024-08-01)

Expression of interleukin 1-alpha, interleukin 6 and CD 10 in predicting recurrence of ameloblastoma
by: Nurhazwani Mohd Danil, et al.
Published: (2025-07-01)

Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
by: Sajjad M. Alfadul, et al.
Published: (2024-12-01)

Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019
by: Abdulraheem Y. Majeed, et al.
Published: (2023-02-01)

Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy
by: Daniel D. Shapiro, et al.
Published: (2023-05-01)

The Association of the Altered Interleukin-17 and Interleukin-21 Serum Levels with the Occurrence of Autoimmune Thyroid Diseases
by: Hadi Hussein Hamad, et al.
Published: (2026-01-01)

Evaluation of serum levels of interleukins 6, 8, 17 and 22 in acne vulgaris: A cross-sectional study
by: Sweta Singh, et al.
Published: (2023-01-01)

Adjuvant Chemotherapy and Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: A Systematic Review and Clinical Practice Guideline
by: James J. Biagi, et al.
Published: (2023-07-01)

Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components
by: Ying Li, et al.
Published: (2024-02-01)

Estimation of Interleukin 32 and Interleukin 37 Serum Levels in Iraqi Patients with Rheumatoid Arthritis
by: E Mohammed Jasim, et al.
Published: (2023-04-01)

Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor  on cancer cells
by: Konrad Kwaśniak, et al.
Published: (2019-07-01)

Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 – An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives
by: Tatu AL, et al.
Published: (2022-09-01)

An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma
by: Brianna J. McIntosh, et al.
Published: (2023-11-01)

Interleukin biomarkers as predictive tools for lupus nephritis grade and disease activity in systemic lupus erythematosus
by: Dalia S. Saif, et al.
Published: (2025-04-01)

Evaluation of Serum Interleukin 35 and Interleukin 38 and Electrolyte Level in the Sera of Rheumatoid Arthritis and Osteoarthritis Iraqi Females
by: Montadher Ali Mahdi, et al.
Published: (2024-09-01)

Modulation of TNF‐α, interleukin‐6, and interleukin‐10 by nebivolol–valsartan and nebivolol–lisinopril polytherapy in SHR rats
by: Lezama‐Martinez Diego, et al.
Published: (2024-04-01)

Evaluation of selected circulating cytokines from the IL-6 family – interleukin 6, oncostatin M, and cardiotrophin-1 – in gastro-entero-pancreatic and bronchial neuroendocrine tumours
by: Janusz Strzelczyk, et al.
Published: (2024-08-01)

Role of interleukin 1β and interleukin 10 variants on ocular toxoplasmosis in Brazilian individuals
by: Warlen Miiller Rocha Araujo, et al.
Published: (2023-06-01)